Sartorius Stedim Biotech (FR:DIM) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sartorius Stedim Biotech reported a strong liquidity position in its half-year statement, with a total of 46,292 shares and €2,521,189.91 in cash on their liquidity account as of June 30th, 2024. The company, a key international player in the biopharmaceutical industry, supports the production of biotech medications and has a global presence with a workforce of over 10,600 employees.
For further insights into FR:DIM stock, check out TipRanks’ Stock Analysis page.
